Frontlight ResearchEarly access
CompletedPhase 4
The Effect of Dexmedetomidine Infusion Alone Versus the Combination of Dexmedetomidine and Melatonin on Reduction of Post-operative Delirium (POD) After Open Brain Surgeries
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 100 people enrolled
- Started
- 1 Aug 2025
- Ended
- 1 Feb 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexmedetomidine (DEX)
- Melatonin
- Record updated
- 16 March 2026
Who can take part
- Age
- 30 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age: 30 - 60 years
- Sex: Both sexes
- Patients with open space occupying lesions or hematoma
Who cannot take part
- Any form of drug addiction
- Patients receiving any anti-psychotic medications
- History of previous brain insult (Ischemic or haemorrhagic infarctions)
- History of allergy to the medications used in the study
- Psychiatric disorder
- Pre-operative dementia
- History of malignant hyperthermia
- Refusal of the patient to give written informed consent
- Patient's suffering from bradycardia
- Patient's suffering from hypotension
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to illuminate the effect of combination of dexmedetomidine and oral melatonin versus the use of dexmedetomidine infusion alone on the improving of post-operative delirium (POD) on patients undergoing open brain surgeries.
The 2 groups in the trial
- Control GroupExisting treatment, for comparison
Dexmedetomidine alone
Treatment: Dexmedetomidine (DEX)
- Combination GroupExisting treatment, for comparison
Combination of Dexmedetomidine \& Melatonin
Treatment: Dexmedetomidine (DEX) and Melatonin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 16 March 2026